RHNMF   $0.0264  -45.00% Market Closed

Rhinomed Ltd
Last Events:

2023-07-18 Signal in Stochastic changed from bearish to bearish recovery. The stochastic indicator is in the oversold territory and it heading south. These factors indicate that the downside potential still holds even though the market is oversold. Last signal: entry into the oversold zone.

2023-07-18 Signal in MACD changed from bearish weakening to bearish recovery. Oscillator MACD is in the negative territory it's lower than the signal line and falls. These factors mean that negative mood prevails. Last signal: entry into the oversold zone.

2023-07-18 Signal in RSI changed from bearish weakening to bearish recovery. RSI indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: exit from the overbought zone.

2023-07-18 Signal in EMA100 changed from bearish reversal to n/a.

2023-07-18 Signal in EMA20 changed from bearish reversal to n/a. 2022-04-28 the price crossed down the moving average line and demonstrates a strong downside trend.

2023-07-18 Trend Power changed from slow to strong.

2023-03-29 Trend pattern changed from нисходящий треугольник to сужающийся канал.

2023-03-29 Signal in Stochastic changed from bullish reversal to bearish. The stochastic indicator is in the oversold territory and it heading north. These factors indicate that perhaps the downside trend is coming to an end. Last signal: signal line crossed the middle level.


Current temperature: 0.00
ST: 0, Cor:

Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Sell Sell -
rsi ActivelyBuy - -
macd - - -
stoch - - -
ma20 Sell - -
ma50 - - -
ma100 Sell Sell -
Candlestick PatternJune 27, 2022 Doji - is formed when the open and the close are the same or very close. The body of candle is small. The length of the shadows are not important. The appearance of a Doji should alert the investor of major indecision.
ISIN AU000000RNO1
ceo Mr. Michael Johnson
Website https://www.rhinomed.global
Rhinomed Limited engages in the research, development, and commercialization of consumer and medical devices worldwide. The company offers wearable nasal technology that improve breathing, sleeping, and maintaining health and diagnose disease. Its products include Turbine for enhanced breathing in sports; Mute, which helps to breath more and snore less; Pronto, a vapor inhaler to improve airflow and better sleep; and Rhinoswab that is used to collect a nasal swab. The company also engages in developing programs in various markets, including sleep and sleep architecture, the impact of sleep and respiratory, function on cognitive issues, obstructive sleep apnea, pain, nausea, respiratory disease, and diagnostics and sensors; and offers a drug delivery platform for the delivery of cannabinoid formulations. The company was formerly known as Consegna Group Limited and changed its name to Rhinomed Limited in November 2013. Rhinomed Limited was incorporated in 2004 and is based in Cremorne, Australia.